GENEVA, July 2 -- FUJII, Jun filed a patent application (JP2025/039734) for “CELL-BASED FORMULATION CONTAINING PLURIPOTENT STEM CELLS FOR DISEASES OR POST-ACUTE SEQUELAE CAUSED BY SARS-COV-2 INFECTION”. With publication no. WO/2026/133815, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 35/28
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....